河南太龙药业2025年度业绩及现金分红说明会公告时间、参与方式及详情

河南太龙药业股份有限公司召开2025年度业绩暨现金分红说明会公告详解

公告要点梳理

会议时间：2026年4月24日（星期五）13:00-14:45
会议地点：上海证券交易所上证路演中心（https://roadshow.sseinfo.com/）
会议形式：视频结合网络文字互动，投资者可通过互联网参与
参与方式：
- 投资者可在会议当天在线参与、实时提问
- 提前提问时间：2026年4月17日至4月23日16:00，可通过“提问预征集”栏目或邮箱（[email protected]）提交问题
参与人员：董事长、独立董事、财务负责人、董事会秘书（如有特殊情况，人员可能调整）
会议内容：2025年度经营成果、财务状况及利润分配事项，重点回答投资者关注问题并听取意见建议
联系方式：公司证券部，电话：0371-67982194，邮箱：[email protected]
会后信息：投资者可通过上证路演中心回看说明会内容

对投资者和股东的重要影响及潜在价格敏感信息

年度报告与利润分配方案已公布：公司已于2026年4月15日发布《2025年年度报告》和《2025年度利润分配方案公告》。此次说明会将详解这些内容，涉及年度经营成果、财务状况和现金分红政策。
现金分红方案：利润分配方案内容极为重要，直接涉及股东回报，若分红比例较高或有超预期变化，可能会对股价产生积极影响。
投资者互动与信息透明：公司通过公开说明会与投资者互动，回答普遍关注的问题，体现信息披露的透明度，有助于提升市场信心。
董事高管参与：高管团队直接参与答疑，说明公司对投资者关系重视，若有重大经营或分红政策调整，将现场解答，可能影响市场预期。
投资者可提前提问：投资者可提前提交问题，公司将在说明会重点回应普遍关注事项，若涉及重大经营、财务变化或未来展望，可能成为价格敏感信息。

详细说明会安排与参与方式

本次说明会采用视频结合网络文字互动方式，投资者可通过“上证路演中心”网站参与。会议期间，公司将对2025年度经营成果、财务状况、利润分配等事项进行全面解答，并收集投资者建议。提前提问渠道包括网站“提问预征集”栏目和公司邮箱，投资者可提前提交问题，公司将在说明会统一回应。

会议结束后，投资者可在上证路演中心网站回看会议内容，包括主要问答和讨论情况。

投资者须关注事项

现金分红及利润分配方案的具体内容会在说明会上重点解读，直接影响股东回报。
说明会可能披露公司未来经营计划、财务策略或重大事项，投资者需密切关注。
投资者有机会直接参与互动，提出关心问题，获取一手信息。
如有重大调整或利好消息，可能成为驱动股价的重要因素。

免责声明

本文仅为信息解读，不构成投资建议。投资者应结合公司正式公告及自身判断，理性决策。公司未来业绩及分红政策以正式公告为准，股价波动受多重因素影响，投资需谨慎。

Detailed Article in English

Key Highlights from the Announcement

Meeting Date: April 24, 2026 (Friday), 13:00-14:45
Location: Shanghai Stock Exchange Roadshow Center (https://roadshow.sseinfo.com/)
Format: Video with online Q&A, investors can participate remotely
Participation Channels:
- Investors may join live and ask questions during the meeting
- Advance question submission: April 17 to April 23, 16:00, via “Question Collection” or email ([email protected])
Participants: Chairman, Independent Directors, CFO, Board Secretary (subject to change if necessary)
Content: 2025 business results, financial status, profit distribution; focus on investor concerns and collecting feedback
Contact: Securities Department, Tel: 0371-67982194, Email: [email protected]
Post-meeting Information: Investors can review meeting content on the Roadshow Center website

Potential Price-sensitive Information and Shareholder Impact

Annual Report & Dividend Plan Released: Taolong Pharma has published its 2025 annual report and dividend plan on April 15, 2026. The meeting will elaborate on these, covering business results, financials, and cash dividends.
Cash Dividend Policy: The profit distribution plan is highly relevant for shareholders, directly affecting shareholder returns. Any surprise in dividend amount or policy may influence share price.
Transparency & Investor Engagement: The company’s open Q&A fosters transparency, enhancing market confidence.
Top Management Participation: With key executives attending, the meeting may reveal major operational or dividend policy changes, possibly affecting investor expectations and share value.
Advance Investor Questions: Investors can submit questions in advance, and the company will address widely concerned topics. If major business or financial changes are discussed, this could be price-sensitive.

Detailed Meeting Arrangements & Participation

The meeting will be held via video and online Q&A on the Roadshow Center website. It will cover 2025 business results, financials, and dividend matters, with detailed answers and feedback collection. Investors can submit questions in advance via the website or email, and the company will respond during the meeting.

After the meeting, investors can review content including Q&A and discussions on the Roadshow Center website.

What Investors Should Watch For

The cash dividend and profit distribution details will be explained, directly impacting shareholder returns.
The meeting may reveal future business strategies or major matters, which investors should closely monitor.
Investors have the opportunity for direct interaction and access to first-hand information.
Any significant adjustments or positive news may drive the share price.

Disclaimer

This article is for information purposes only and does not constitute investment advice. Investors should refer to official company announcements and exercise independent judgment. Company performance and dividend policy are subject to formal disclosures, and share prices are affected by multiple factors. Invest cautiously.